Delivery Order SPE2DB22D2206-SPE2DB26FDS79
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $3,081.89 and a firm fixed-price structure. This competitively awarded delivery order, which carries no set-aside designation, is expected to reach ultimate completion on September 2, 2025, with performance taking place at the contractor's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,361.04 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with a completion deadline of August 18, 2025, and was awarded through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The award, valued at $24,464.62, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract is scheduled for ultimate completion on September 24, 2025,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 26, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,302.86. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $13,932.60 and a firm fixed price structure. The delivery order carries an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS79Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency for the supply of Lidocaine 5% Patch 30-count units. This firm fixed price delivery order, valued at $11,216.59 with an ultimate completion date of October 23, 2025, represents a competitively awarded, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The Lidocaine 5% Patch delivery fulfills critical pharmaceutical supply needs within the Defense Logistics Agency's Medical Supply Chain, supporting military healthcare programs and associated federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capacity as a major pharmaceutical distributor providing diverse medical products ranging from specialty medications and generic drugs to medical devices and supplies across multiple therapeutic domains. This award reflects the contractor's consistent capability to meet federal procurement requirements through competitive procurement processes and delivers pain management pharmaceuticals essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 10/22/25 |